In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 14, 2008, Pages 5550-5557

  Li, Yong Mei ^a   Li, Xiao Mian ^a   Li, Guang Ming ^a   Du, Wen Cai ^a   Zhang, Jing ^a   Li, Wei Xia ^a   Xu, Jianshe ^a   Hu, Ming ^b   Zhu, Ze ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Bioavailability; Biotransformation; Chenpi; Glycosidase; Hesperidin; Pharmacokinetics

Indexed keywords

BETA GLUCURONIDASE; FUNGAL PROTEIN; GLUCOSIDASE; HESPERIDIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BASIDIOMYCETES; BIOAVAILABILITY; BLOOD; HYDROLYSIS; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; BASIDIOMYCOTA; BIOLOGICAL AVAILABILITY; FUNGAL PROTEINS; GLUCOSIDASES; GLUCURONIDASE; HESPERIDIN; HYDROLYSIS; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

CITRUS; ESCHERICHIA COLI; RATTUS; SPOROBOLOMYCES SINGULARIS;

EID: 49049095051     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800105c     Document Type: Article

References (29)

1. Mouly, P.; Gaydou, E. M.; Auffray, A. Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J. Chromatogr., A 1998, 800 (2), 171-9.
2. Yeh, C. C.; Kao, S. J.; Lin, C. C.; Wang, S. D.; Liu, C. J.; Kao, S. T. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 2007, 80 (20), 1821-31.
3. Kim, J. Y.; Jung, K. J.; Choi, J. S.; Chung, H. Y. Hesperetin: A potent antioxidant against peroxynitrite. Free Radical Res. 2004, 38 (7), 761-9.
4. Wilcox, L. J.; Borradaile, N. M.; de Dreu, L. E.; Huff, M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res. 2001, 42 (5), 725-34.
5. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; Rissanen, H.; Heliovaara, M.; Reunanen, A.; Hakulinen, T.; Aromaa, A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76 (3), 560-8.
6. Tanaka, T.; Kohno, H.; Mori, H. Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac. J. Cancer Prev. 2001, 2 (3), 165-177.
7. Yamaguchi, M.; Hamamoto, R.; Uchiyama, S.; Ishiyama, K. Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro. Mol. Cell. Biochem. 2007, 303 (1-2), 83-8.
8. Erlund, I.; Meririnne, E.; Alfthan, G.; Aro, A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr. 2001, 131 (2), 235-41.
9. Gil-Izquierdo, A.; Gil, M. I.; Ferreres, F.; Tomas-Barberan, F. A. In vitro availability of flavonoids and other phenolics in orange juice. J. Agric. Food Chem. 2001, 49 (2), 1035-41.
10. Kanaze, F. I.; Bounartzi, M. I.; Georgarakis, M.; Niopas, I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 2007, 61 (4), 472-7.
11. Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; Remesy, C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 2003, 57 (2), 235-42.
12. Ross, J. A.; Kasum, C. M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22, 19-34.
13. Yamada, M.; Tanabe, F.; Arai, N.; Mitsuzumi, H.; Miwa, Y.; Kubota, M.; Chaen, H.; Kibata, M. Bioavailability of glucosyl hesperidin in rats. Biosci., Biotechnol., Biochem. 2006, 70 (6), 1386-94.
14. Jeong, E. J.; Liu, X.; Jia, X.; Chen, J.; Hu, M. Coupling of conjugating enzymes and efflux transporters: Impact on bioavailability and drug interactions. Curr. Drug Metab. 2005, 6 (5), 455-68.
15. Kobayashi, S.; Tanabe, S.; Sugiyama, M.; Konishi, Y. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers. Biochim. Biophys. Acta 2007.
16. Liu, Y.; Liu, Y.; Dai, Y.; Xun, L.; Hu, M. Enteric disposition and recycling of flavonoids and ginkgo flavonoids. J. Altern. Complement. Med. 2003, 9 (5), 631-40.
17. Walgren, R. A.; Walle, U. K.; Walle, T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 1998, 55 (10), 1721-7.
18. Walle, U. K.; French, K. L.; Walgren, R. A.; Walle, T. Transport of genistein-7-glucoside by human intestinal CACO-2 cells: Potential role for MRP2. Res. Commun. Mol. Pathol. Pharmacol. 1999, 103 (1), 45-56.
19. Kim, D. H.; Jung, E. A.; Sohng, I. S.; Han, J. A.; Kim, T. H.; Han, M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 1998, 21 (1), 17-23.
20. Lee, N. K.; Choi, S. H.; Park, S. H.; Park, E. K.; Kim, D. H. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 2004, 71 (4), 174-80.
21. van Rooyen, R.; Hahn-Hagerdal, B.; La Grange, D. C.; van Zyl, W. H. Construction of cellobiose-growing and fermenting Saccharomyces cerevisiae strains. J. Biotechnol. 2005, 120 (3), 284-95.
22. Li, X. L.; Ljungdahl, L. G.; Ximenes, E. A.; Chen, H.; Felix, C. R.; Cotta, M. A.; Dien, B. S. Properties of a recombinant beta-glucosidase from polycentric anaerobic fungus Orpinomyces PC-2 and its application for cellulose hydrolysis. Appl. Biochem. Biotechnol. 2004, 113-116, 233-50.
23. Ma, Y. Y.; Xingqian; Yunbin, H.; Guoneng, X.; Guihua, X.; Donghong, L. Ultrasound-assisted extraction of hesperidin from Penggan (Citrus reticulata) peel. Ultrason. Sonochem. 2008, 15 (3), 227-32.
24. Ishikawa, E.; Sakai, T.; Ikemura, H.; Matsumoto, K.; Abe, H. Identification, cloning, and characterization of a Sporobolomyces singularis beta-galactosidase-like enzyme involved in galacto- oligosaccharide production. J. Biosci. Bioeng. 2005, 99 (4), 331-9.
25. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London, U.K.) 1970, 227 (5259), 680-5.
26. Nielsen, I. L.; Chee, W. S.; Poulsen, L.; Offord-Cavin, E.; Rasmussen, S. E.; Frederiksen, H.; Enslen, M.; Barron, D.; Horcajada, M. N.; Williamson, G. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial. J. Nutr. 2006, 136 (2), 404-8.
27. Liu, Y.; Hu, M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab. Dispos. 2002, 30 (4), 370-7.
28. Silberberg, M.; Morand, C.; Mathevon, T.; Besson, C.; Manach, C.; Scalbert, A.; Remesy, C. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur. J. Nutr. 2006, 45 (2), 88- 96.
29. Liu, Z.; Hu, M. Natural polyphenol disposition via coupled metabolic pathways. Expert Opin. Drug Metab. Toxicol. 2007, 3 (3), 389-406.